Key Financial’s Lexeo Therapeutics LXEO Stock Holding History
Bought
Maintained
Sold
Other funds holding LXEO
Key Financial's LXEO Position: Q3 2026 in Review
Key Financial held its Lexeo Therapeutics (LXEO) position steady in Q3 2026 at 200 shares worth $676. The position accounts for ﹤0.01% of the portfolio, ranked #1204.
Key Financial first reported a position in LXEO in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.15K in Q1 2026. 97 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.
- Key Financial held 200 shares of Lexeo Therapeutics worth $676 as of Q3 2026.
- Key Financial left its Lexeo Therapeutics share count unchanged in Q3 2026.
- Lexeo Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1204 holding.
- Key Financial first reported a position in Lexeo Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Key Financial's Lexeo Therapeutics position peaked at $1.15K in Q1 2026.
- 97 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.